Marianne Bjørdal
InvestorPartner at 3B Future Health Fund
France
Writes $100K – $5M checks · typically $1.5M
About
Marianne Bjørdal is a Partner at 3B Future Health Ventures, part of the Helsinn Group. She has a background in life science research and investment management, with focus on drug development and early-stage ventures.
Experience
- Helsinn Group -3B Future Health VenturesPartnercurrent2022 — present
- Helsinn Group -3B Future Health VenturesSenior Associate2019 — 2022
- Helsinn Group -3B Future Health VenturesInvestment Analyst2018 — 2019Monaco area
- Sibylla BiotechBoard Membercurrent2022 — present
- Epsilogen LtdBoard membercurrent2022 — present
- Kither BiotechBoard Observercurrent2022 — present
- Navion incBoard membercurrent2021 — present
- NeoPhore LtdBoard membercurrent2021 — present
- Gain TherapeuticsBoard Member2020 — 2021
- VirbacProject Monitor2018Nice Area, France
- CNRSResearcher2012 — 2017Nice Area, France
- CNRSPhD fellow2005 — 2011
- Norges forskningsrådPhD fellow2006 — 2011
- Sars International Centerresearch2000 — 2006
- Sars International Center for Marine Molecular BiologyResearch assistent2003 — 2005
Skills & more
Life Sciences5Biotechnology2venture capital1Science2Pharmaceutical IndustryResearch and Development (R&D)2Project Management2NeuroscienceBusiness1Project Planning1Genetics1Marketing Strategy
+4 more
FrenchEnglishNorwegianDrosophilaLanguages English · French · Norwegian
From Marianne's professional profile.
Colleagues at 3B Future Health Fund
Alessandro Santoboni
Managing Director and General Partner at 3B Future Health Fund
Carlos von Bonhorst
Strategic Advisor at 3B Future Health Fund
Fabio Mastrosimone
Investor at 3B Future Health Fund
Francesco Giavatto
Chief Financial Officer and General Partner at 3B Future Health Fund
Francesco Granata
Strategic Advisor and General Partner at 3B Future Health Fund
Karin Hehenberger
Strategic Advisor at 3B Future Health Fund
Marianne Bjordal
General Partner at 3B Future Health Fund
Paolo Paoletti
Strategic Advisor at 3B Future Health Fund
Network2
Fabio Mastrosimone
Investor at 3B Future Health Fund
Francesco Granata
Strategic Advisor and General Partner at 3B Future Health Fund
Investors connected to Marianne in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Marianne Bjørdal?
- Marianne Bjørdal is a Partner at 3B Future Health Ventures, part of the Helsinn Group. She has a background in life science research and investment management, with focus on drug development and early-stage ventures.
- Where does Marianne Bjørdal work?
- Marianne Bjørdal is Partner at 3B Future Health Fund.
- What check size does Marianne Bjørdal write?
- Marianne Bjørdal typically writes checks of $100K – $5M.
- Where did Marianne Bjørdal go to school?
- Marianne Bjørdal studied at Université Côte d'Azur (Doctor of Philosophy (Ph.D.), Developmental and cellular biology); IAE Nice (Graduate School of Management) (Master of Business Administration - MBA); University of Bergen (UiB) (Cand. scient, Molecular biology).
Same school
Also attended Université Côte d'Azur14
Ioanna ChrysanthouPeople Lead at SpeedinvestHelen AgeringPartner at Spintop VenturesPierre GentoliPartner & Chief Financial Officer at Monaco Global Services MFOGladeys RodriguezInvestment Analyst at SquareOne CapitalTim RyanInvestor at Vibe CapitalChristopheInvestor at Basinghall Partners
+ 8 more
Also attended IAE Nice (Graduate School of Management)2
Also attended University of Bergen (UiB)21
RonnyInvestor at InvestinorVibekeInvestor at InvestinorThor Olav Thorsnes EgelandManaging Director at Statkraft VenturesØivind EngerPartner, Life Sciences at Sarsia Management ASHilde HoldhusPartner, Technology, Energy and Sustainability at Sarsia Management ASNatalie MildeInvestment Associate at Future Energy Ventures
+ 15 more
